Article Versions Notes

Weksler M, Simon A, Lenkinski RE, Landsman H, Matzkin H, Mabjeesh N, Leibovitch I. A Novel Modality Enables New Evidence-Based Individual Risk Stratification That Can Potentially Lead to Decisive Management and Treatment Decisions in Prostate Cancer. Diagnostics. 2023; 13(3):424. https://doi.org/10.3390/diagnostics13030424

Weksler, Meir, Avi Simon, Robert E. Lenkinski, Hagar Landsman, Haim Matzkin, Nicola Mabjeesh, and Ilan Leibovitch. 2023. "A Novel Modality Enables New Evidence-Based Individual Risk Stratification That Can Potentially Lead to Decisive Management and Treatment Decisions in Prostate Cancer" Diagnostics 13, no. 3: 424. https://doi.org/10.3390/diagnostics13030424

Weksler, M., Simon, A., Lenkinski, R. E., Landsman, H., Matzkin, H., Mabjeesh, N., & Leibovitch, I. (2023). A Novel Modality Enables New Evidence-Based Individual Risk Stratification That Can Potentially Lead to Decisive Management and Treatment Decisions in Prostate Cancer. Diagnostics, 13(3), 424. https://doi.org/10.3390/diagnostics13030424